Skip to main content
Fig. 12 | Cancer Nanotechnology

Fig. 12

From: Preparation and characterization of the myricetin-loaded solid lipid nanoparticles decorated with folic acid-bound chitosan and evaluation of its antitumor and anti-angiogenic activities in vitro and in vivo in mice bearing tumor models

Fig. 12

Antitumor activities of myricetin-SLN-CS-FA on mice bearing subcutaneous TUBO cells tumor model treated with free myricetin and two doses of myricetin-SLN-CS-FA (25 and 50 mg/kg) which administrated using oral gavage. A The results of tumor volume during the 26 days of the study. B The results of animal weights during the 26 days of the study. C The weights of the tumor tissues on day 26 after tumor inoculation (*p < 0.05 and ***p < 0.001). The data were presented as mean ± SD. The test was performed in triplicate

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us